Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.
(2024) European Journal of Cancer — Vol. 213, p. 115073 [1-13] (2024)
Files
RossiCEurJCancer2024.pdf
Open Access - Adobe PDF
- 4.01 MB
Details
- Authors
- Abstract
- Classic Hodgkin lymphoma (HL) is a distinct entity among hematological malignancies of B-cell origin. It is characterized by its unique histopathological features and generally favorable prognosis. Over the years, advancements in understanding its pathogenesis, coupled with refined diagnostic and evaluation modalities, as well as therapeutic strategies, have significantly transformed the landscape of HL management. In this article, we present a comprehensive set of recommendations for the management of HL, encompassing various aspects of diagnosis, risk stratification, evaluation, and treatment. These recommendations are based on the latest evidence-based guidelines, expert consensus opinions, and clinical trial data, aiming to provide clinicians with a practical framework for delivering optimal care to patients with HL.
- Affiliations
Citations
Rossi, C., Manson, G., Marouf, A., Cabannes-Hamy, A., Nicolas-Virelizier, E., Maerevoet, M., Alcantara, M., Molina, L., Ceraulo, A., Poirée, M., Galtier, J., Diop, N., Delette, C., Segot, A., Dubois, S., Waultier, A., Bernard, S., Noël, R., Guidez, S., et al. (2024). Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines. European Journal of Cancer, 213, 115073 [1-13]. https://doi.org/10.1016/j.ejca.2024.115073 (Original work published 2024)